REVENUE (Tables)

3 Months Ended

Mar. 31, 2025

Revenue from Contract with Customer [Abstract]

Schedule of Revenue by Segment by Geographic Area

Revenue by segment and geography based on shipped to locations for the three months ended March 31, 2025 and 2024 were as follows:

	For the Three Months Ended March 31, 2025
Segment	Europe		Domestic		Latin America		Asia		Total
Aptar Pharma	$	198,693	$	141,661	$	11,981	$	57,132	$	409,467
Aptar Beauty	187,909		58,197		39,586		20,015		305,707
Aptar Closures	52,044		82,599		20,947		16,541		172,131
Total	$	438,646	$	282,457	$	72,514	$	93,688	$	887,305

	For the Three Months Ended March 31, 2024
Segment	Europe		Domestic		Latin America		Asia		Total
Aptar Pharma	$	212,175	$	125,810	$	12,622	$	56,686	$	407,293
Aptar Beauty	206,190		63,277		38,187		19,666		327,320
Aptar Closures	56,027		88,816		21,273		14,719		180,835
Total	$	474,392	$	277,903	$	72,082	$	91,071	$	915,448

Schedule of Contract Assets and Contract Liabilities

The opening and closing balances of our contract asset and contract liabilities were as follows:

	Balance as of March 31, 2025		Balance as of December 31, 2024		Increase/ (Decrease)
Contract asset (current)	$	12,023	$	12,571	$	(548)
Contract liability (current)	80,000		64,425		15,575
Contract liability (long-term)	46,400		40,551		5,849